it's interesting that no announcement has been made on how our testosterone generic is going sales wise seeing it was launched in August last year. With 4 months to the end of the year for cashflow positive projections (fingers crossed) and the filing of 4 more dossiers .......... ACR would know. Hopefully the AGM in Sept (?) will be very good.
News: ACR Acrux Says Its Sixth Generic Application Accepted By U.S. FDA For Review, page-6
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.001(1.92%) |
Mkt cap ! $14.82M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $21.56K | 426.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 140000 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 175307 | 1 |
View Market Depth
| Last trade - 11.06am 06/11/2024 (20 minute delay) ? |
| ACR (ASX) Chart |